Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Invictus MD Strategies Corp IVITF

Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II expansion and received its amended license from Health Canada. Another of its wholly owned subsidiary, connects medical clients to physicians for medical cannabis.


GREY:IVITF - Post by User

Comment by makinprofiton Feb 10, 2019 7:40pm
170 Views
Post# 29344678

RE:Poda shares

RE:Poda sharesFor over a month I had an amount of shares of an unnamed company (only listed in my acct as    N)A  ).equal to my GENE shares.That changed recently .The explanation was given in a post by juspam1  on Feb 6th.
Vancouver, BC, January 31, 2019 – PODA TECHNOLOGIES LTD. ("Poda" or the "Company") is pleased to announce that it has completed its previously announced consolidation of its issued and outstanding Class A common shares on the basis of 1 new post-consolidation share for every 4.508 preconsolidation shares (the "Consolidation"), with an effective date of January 31, 2019. Following the Consolidation, the number of issued and outstanding shares of the Company will be reduced from approximately 112,176,712 pre-consolidation shares to approximately 24,883,916 post-consolidation shares. No fractional shares will be issued in connection with the Consolidation. The Consolidation is being conducted on a push-out basis. The Company's new CUSIP for the postconsolidation shares is 73044H206 and the ISIN for the post-consolidation shares is CA73044H2063. Shareholders who hold their shares in brokerage accounts or “street name” are not required to take any action to affect the exchange of their shares
Read more at https://stockhouse.com/companies/bullboard#7D4k5jiM0DQyWmk4.99
<< Previous
Bullboard Posts
Next >>